Sage Journals: Discover world-class research

Abstract

Behavioral and social sciences randomized controlled trials (BSSTs) have a significant role in life sciences. Choosing an appropriate control or comparator group for BSSTs is critical, to provide true intervention effects. The objective of this study was to determine the types of control groups used in BSSTs, and the rationale provided to justify these choices. We conducted a systematic survey of BSST protocols published between January 2012 and October 2016 in the Cochrane Library and Medline databases. We randomly selected 200 protocols. The study selection and data extraction were performed independently in duplicate. The most frequent control groups were active concurrent (97/200, 48.5%), and no treatment concurrent controls (88/200, 44.0%). The majority of studies (71.5%) did not provide justification for comparators choice. We concluded that BSSTs trials compare interventions to active and no treatment controls however the majority of trials lacked rationale for the selection of the study comparator.

Keywords

systematic survey comparator behavioral and social sciences research

Get full access to this article

View all access options for this article.

References

Anderson

N. B.

(1997). Integrating behavioral and social sciences research at the National Institutes of Health, U.S.A. Social Science & Medicine, 44, 1069–1071.

Brigham

G. S.

Feaster

D. J.

Wakim

P. G.

Dempsey

C. L.

(2009). Choosing a control group in effectiveness trials of behavioral drug abuse treatments. Journal of Substance Abuse Treatment, 37, 388–397. doi:10.1016/j.jsat.2009.05.004

Campbell

A. N.

Nunes

E. V.

Miele

G. M.

Matthews

Polsky

Ghitza

U. E.

… Crowell

A. R.

(2012). Design and methodological considerations of an effectiveness trial of a computer-assisted intervention: An example from the NIDA Clinical Trials Network. Contemporary Clinical Trials, 33, 386–395. doi:10.1016/j.cct.2011.11.001

Center for Medical Technology Policy. (2010). Pragmatic Phase 3 Pharmaceutical Trials: Recommendations for the design of clinical trials that are more informative for patients, clinicians, and payers. Retrieved June 9, 2017, from http://www.cmtpnet.org/docs/resources/PCT3_EGD.pdf

Chan

A. W.

Song

Vickers

Jefferson

Dickersin

Gotzsche

P. C.

… van der Worp

H. B.

(2014). Increasing value and reducing waste: Addressing inaccessible research. Lancet, 383, 257–266. doi:10.1016/s0140-6736(13)62296-5

Dawson

Zarin

D. A.

Emanuel

E. J.

Friedman

L. M.

Chaudhari

Goodman

S. N.

(2009). Considering usual medical care in clinical trial design. PLoS Med, 6, e1000111. doi:10.1371/journal.pmed.1000111

European Medicines Agency. (2001). ICH Topic E10 Choice of Control Group in Clinical Trials. Retrieved June 9, 2017, from http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002925.pdf

Food and Drug Administration. (2001). Guidance for industry E 10 choice of control group and related issues in clinical trials. Retrieved June 9, 2017, from http://www.fda.gov/cder/guidance/index.htm

Hudson

K. L.

Lauer

M. S.

Collins

F. S.

(2016). Toward a new era of trust and transparency in clinical trials. Journal of the American Medical Association, 316, 1353–1354. doi:10.1001/jama.2016.14668

10.

Karanicolas

P. J.

Farrokhyar

Bhandari

(2010). Practical tips for surgical research: Blinding: Who, what, when, why, how? Canadian Journal of Surgery, 53, 345–348.

11.

Kelly

L. E.

Davies

E. H.

Saint-Raymond

Tomasi

Offringa

(2016). Important issues in the justification of a control treatment in paediatric drug trials. Archives of Disease in Childhood, 101, 962–967. doi:10.1136/archdischild-2016-310644

12.

Kim

Shin

(2014). How to do random allocation (randomization). Clinics in Orthopedic Surgery, 6, 103–109. doi:10.4055/cios.2014.6.1.103

13.

Mann

Djulbegovic

(2003). Choosing a control intervention for a randomised clinical trial. BMC Medical Research Methodology, 3, 7. doi:10.1186/1471-2288-3-7

14.

Marsden

Stillwell

Hellier

Brown

A. M.

Byford

Kelleher

… Mitcheson

(2017). Effectiveness of adjunctive, personalised psychosocial intervention for non-response to opioid agonist treatment: Study protocol for a pragmatic randomised controlled trial. Contemporary Clinical Trials, 53, 36–43. doi:10.1016/j.cct.2016.12.003

15.

McGrath

J. E.

(1995). Methodology matters: Doing research in the behavioral and social sciences. In Baecker

R. M.

Grudin

Buxton

W. A. S.

Greenberg

16.

Michie

van Stralen

M. M.

West

(2011). The behaviour change wheel: A new method for characterising and designing behaviour change interventions. Implementation Science, 6, 42. doi:10.1186/1748-5908-6-42

17.

Sackett

D. L.

Wennberg

J. E.

(1997). Choosing the best research design for each question. British Medical Journal, 315, 1636.

18.

Samaan

Litke

McCabe

Dennis

Whattam

Garrick

… Thabane

(2015). A pragmatic pilot randomized trial to investigate the effectiveness of behavioural activation group therapy in reducing depressive symptoms and improving quality of life in patients with depression: The BRAVE pilot trial protocol. Pilot and Feasibility Studies, 1, 39. doi:10.1186/s40814-015-0034-y

19.

Schulz

K. F.

Chalmers

Hayes

R. J.

Altman

D. G.

(1995). Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. Journal of the American Medical Association, 273, 408–412.

20.

Schwartz

Lellouch

(1967). Explanatory and pragmatic attitudes in therapeutical trials. Journal of Chronic Diseases, 20, 637–648. doi:10.1016/0021-9681(67)90041-0

21.

Smelt

A. F.

van der Weele

G. M.

Blom

J. W.

Gussekloo

Assendelft

W. J.

(2010). How usual is usual care in pragmatic intervention studies in primary care? An overview of recent trials. British Journal of General Practice, 60, e305–e318. doi:10.3399/bjgp10X514819

22.

World Medical Association. (1997). Declaration of Helsinki: Recommendations guiding physicians in biomedical research involving human subjects. Journal of the American Medical Association, 277, 925. doi:10.1001/jama.1997.03540350075038

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.11 MB

A Systematic Survey of Control Groups in Behavioral and Social Science Trials

Abstract

Keywords

Get full access to this article

References

Supplementary Material